The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
RNA interference has become increasingly used for genetic therapy following the rapid development of oligonucleotide drugs. Significant progress has been made in its delivery system and implementation in the treatment of target organs. After a brief introduction of RNA interference technology and si...
Saved in:
Main Authors: | Lei Zhang (Author), Yayu Liang (Author), Guohui Liang (Author), Zhili Tian (Author), Yue Zhang (Author), Zhihui Liu (Author), Xinying Ji (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022) -
Improved method for synthesis of low molecular weight protamine-siRNA conjugate
by: Zhili Yu, et al.
Published: (2018) -
Insight Into the Prospects for RNAi Therapy of Cancer
by: Zhili Tian, et al.
Published: (2021) -
Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
by: Kamila Butowska, et al.
Published: (2023)